Sanofi American Depositary Shares (Each representing one-half of
SNY Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
$SNY is featured in our Top Gov Contract Recipients strategy.
All StrategiesIncome
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of SNY by members of U.S. Congress
SNY Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
SNY Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
SNY Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in SNY holdings by institutional investors
Quarterly net insider trading by SNY's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$1,100,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Manufacturing
-
$1,590,000 Oct 20, 2025 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,050,000 Jul 21, 2025 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Manufacturing
-
$2,540,000 Apr 21, 2025 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$690,000 Jan 21, 2025 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,815,000 Oct 21, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$860,000 Jul 22, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$60,000 Feb 08, 2024 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Budget/Appropriations Health Issues Medicare/Medicaid
-
$880,000 Jan 22, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$1,520,000 Oct 18, 2023 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$1,870,000 Apr 20, 2022 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$850,000 Jan 20, 2022 Issue: None
-
$1,310,000 Oct 20, 2021 Issue: None
-
$980,000 Jul 21, 2021 Issue: None
-
$1,440,000 Apr 20, 2021 Issue: None
-
$700,000 Jan 20, 2021 Issue: None
-
$1,300,000 Oct 20, 2020 Issue: None
-
$860,000 Jul 20, 2020 Issue: None
-
$1,750,000 Apr 20, 2020 Issue: None
-
$783,000 Jan 21, 2020 Issue: None
-
$40,000 Jul 10, 2019 Issue: Pharmacy Copyright/Patent/Trademark
-
$1,668,000 Apr 22, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Budget/Appropriations Torts
-
$790,000 Jan 22, 2019 Issue: Torts Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,100,000 Jul 20, 2018 Issue: Health Issues Economics/Economic Development Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid
-
$2,030,000 Apr 20, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$600,000 Jan 22, 2018 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,260,000 Oct 20, 2017 Issue: Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$740,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Trade (domestic/foreign) Torts Taxation/Internal Revenue Code
-
$1,896,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Consumer Issues/Safety/Products Pharmacy Torts Medicare/Medicaid
-
$470,000 Jan 20, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Pharmacy Taxation/Internal Revenue Code
-
$31,000 Apr 02, 2016 Issue: Medical/Disease Research/Clinical Labs Homeland Security Health Issues
-
$990,000 Jan 11, 2016 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Animals Pharmacy Trade (domestic/foreign)
-
$940,000 Jan 05, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Economics/Economic Development Animals Medical/Disease Research/Clinical Labs Pharmacy
-
$1,170,000 Oct 14, 2015 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Economics/Economic Development
-
$840,000 Jul 17, 2015 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Economics/Economic Development
-
$1,370,000 Apr 16, 2015 Issue: Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Pharmacy
-
$840,000 Jan 16, 2015 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$940,000 Oct 16, 2014 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Economics/Economic Development Medical/Disease Research/Clinical Labs
-
$720,000 Jul 09, 2014 Issue: Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Economics/Economic Development Copyright/Patent/Trademark Pharmacy
-
$1,570,000 Apr 17, 2014 Issue: Pharmacy Animals Budget/Appropriations Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$790,000 Jan 20, 2014 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Manufacturing Torts
-
$1,310,000 Oct 15, 2013 Issue: Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Manufacturing Copyright/Patent/Trademark
-
$800,000 Oct 15, 2013 Issue: Animals Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Manufacturing
-
$1,590,000 Aug 13, 2013 Issue: Medical/Disease Research/Clinical Labs Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,800,000 Jul 18, 2013 Issue: Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Economics/Economic Development
-
$710,000 Oct 15, 2012 Issue: Health Issues Economics/Economic Development Taxation/Internal Revenue Code Animals Medicare/Medicaid
-
$1,420,000 Jul 19, 2012 Issue: Medical/Disease Research/Clinical Labs Animals Health Issues Taxation/Internal Revenue Code Manufacturing Copyright/Patent/Trademark Economics/Economic Development
-
$750,000 Apr 16, 2012 Issue: Torts Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Manufacturing Copyright/Patent/Trademark Medical/Disease Research/Clinical Labs
-
$710,000 Jan 17, 2012 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,100,000 Oct 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medical/Disease Research/Clinical Labs Torts Medicare/Medicaid
-
$930,000 Jul 19, 2011 Issue: Torts Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$1,860,000 Apr 20, 2011 Issue: Torts Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$623,000 Mar 16, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$950,000 Jan 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
-
$1,380,000 Oct 18, 2010 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
-
$620,000 Oct 13, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$870,000 Jul 19, 2010 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Pharmacy
-
$630,000 Jul 16, 2010 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
-
$1,580,000 Apr 20, 2010 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Pharmacy
-
$920,000 Apr 20, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,430,000 Jan 20, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy
-
$608,000 Jan 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,470,000 Oct 19, 2009 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Pharmacy Copyright/Patent/Trademark
-
$593,000 Oct 08, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,580,000 Jul 17, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Pharmacy
-
$633,000 Jul 13, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,460,000 Apr 20, 2009 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Pharmacy
-
$578,000 Apr 15, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,160,000 Jan 21, 2009 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$594,000 Jan 14, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,270,000 Dec 18, 2008 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
-
$1,480,000 Dec 18, 2008 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
-
$1,190,000 Dec 18, 2008 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Environment/Superfund Copyright/Patent/Trademark
-
$565,000 Oct 17, 2008 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$460,000 Jul 21, 2008 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
-
$440,000 Apr 18, 2008 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$650,000 Feb 14, 2008 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$3,560,000 Feb 11, 2008 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Veterans Defense Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Budget/Appropriations
-
$650,000 Aug 14, 2007 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$3,560,000 Aug 13, 2007 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Veterans Financial Institutions/Investments/Securities Defense Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$3,674,234 Feb 13, 2007 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Financial Institutions/Investments/Securities
-
$600,000 Feb 01, 2007 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$2,006,189 Aug 17, 2006 Issue: Financial Institutions/Investments/Securities Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Veterans Medicare/Medicaid Pharmacy
-
$500,000 Aug 08, 2006 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$2,380,000 Feb 17, 2006 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy Medical/Disease Research/Clinical Labs Torts Copyright/Patent/Trademark
-
$500,000 Feb 14, 2006 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,480,699 Aug 29, 2005 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy Torts
-
$500,000 Aug 16, 2005 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,344,000 Feb 08, 2005 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
-
$500,000 Feb 07, 2005 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$500,000 Aug 19, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,570,000 Aug 12, 2004 Issue: Budget/Appropriations Trade (domestic/foreign) Health Issues Medicare/Medicaid
-
$500,000 Apr 12, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,270,712 Feb 26, 2004 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations
-
$360,000 Aug 14, 2003 Issue: Taxation/Internal Revenue Code Health Issues Trade (domestic/foreign)
-
$1,300,000 Aug 14, 2003 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Torts
-
$360,000 Feb 14, 2003 Issue: Taxation/Internal Revenue Code Health Issues
-
$1,320,000 Feb 14, 2003 Issue: Health Issues Trade (domestic/foreign) Medicare/Medicaid Pharmacy Medical/Disease Research/Clinical Labs
-
$360,000 Aug 14, 2002 Issue: Taxation/Internal Revenue Code Health Issues
-
$1,120,000 Aug 14, 2002 Issue: Medical/Disease Research/Clinical Labs Law Enforcement/Crime/Criminal Justice Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Medicare/Medicaid Labor Issues/Antitrust/Workplace
SNY Estimated quarterly lobbying spending
SNY Revenue by Segment or Geography
By Segment
By Geography
SNY Income Statement
SNY Balance Sheet
SNY Cash Flow
U.S. Patents
New SNY patent grants
-
Patent Title: Humanized anti-cxcr5 antibodies, derivatives thereof and their use Mar. 17, 2015
-
Patent Title: Inhaler for powdery substances, in particular medicinal substances Mar. 17, 2015
-
Patent Title: Anti-alpha2 integrin antibodies and their uses Mar. 10, 2015
-
Patent Title: 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases Mar. 10, 2015
-
Patent Title: Process for synthesizing keto benzofuran derivatives Feb. 24, 2015
-
Patent Title: Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Feb. 24, 2015
-
Patent Title: (heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors Feb. 17, 2015
-
Patent Title: Conjugates, preparation thereof, and therapeutic use thereof Feb. 10, 2015
-
Patent Title: Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives Jan. 27, 2015
-
Patent Title: Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases Jan. 13, 2015
-
Patent Title: Azole derivatives in the form of lipase and phospholipase inhibitors Dec. 30, 2014
-
Patent Title: Dosing device Dec. 23, 2014
-
Patent Title: Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals Dec. 16, 2014
-
Patent Title: Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof Dec. 16, 2014
-
Patent Title: Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring Dec. 09, 2014
-
Patent Title: (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors Dec. 09, 2014
-
Patent Title: Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof Dec. 02, 2014
-
Patent Title: Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof Nov. 25, 2014
-
Patent Title: Process for the preparation of dronedarone Nov. 18, 2014
-
Patent Title: Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof Nov. 18, 2014
-
Patent Title: Process for preparing aminobenzoylbenzofuran derivatives Nov. 11, 2014
-
Patent Title: Method for determining the stability of organic methyleneamines in the presence of semicarbazide-sensitive amine oxidase Nov. 11, 2014
-
Patent Title: Process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives Nov. 04, 2014
-
Patent Title: Method for preparing 3-keto-benzofurane derivatives Oct. 28, 2014
-
Patent Title: Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors Oct. 28, 2014
-
Patent Title: Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof Oct. 28, 2014
-
Patent Title: Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof Oct. 28, 2014
-
Patent Title: Process for the preparation of a compound useful as an inhibitor of tafia Oct. 21, 2014
-
Patent Title: 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof Oct. 21, 2014
-
Patent Title: Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof Oct. 14, 2014
-
Patent Title: Indolizine derivatives, process for the preparation thereof and therapeutic use thereof Oct. 14, 2014
-
Patent Title: Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament Oct. 14, 2014
-
Patent Title: Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Oct. 07, 2014
-
Patent Title: Amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments Oct. 07, 2014
-
Patent Title: Triazolium salts as par1 inhibitors, production thereof, and use as medicaments Oct. 07, 2014
-
Patent Title: Use of vgll3 activity modulator for the modulation of adipogenesis Oct. 07, 2014
-
Patent Title: Antagonist antibodies and their fab fragments against gpvi and uses thereof Oct. 07, 2014
-
Patent Title: 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors Sep. 30, 2014
-
Patent Title: Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring Sep. 30, 2014
-
Patent Title: Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring Sep. 30, 2014
-
Patent Title: Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring Sep. 30, 2014
-
Patent Title: 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof Sep. 30, 2014
-
Patent Title: 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof Sep. 30, 2014
-
Patent Title: Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof Sep. 30, 2014
-
Patent Title: Therapeutic applications in the cardiovascular field of quinazolinedione derivatives Sep. 30, 2014
-
Patent Title: Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs Sep. 23, 2014
-
Patent Title: Use of inhibitors of zdhhc2 activity for modulation of adipogenesis Sep. 23, 2014
-
Patent Title: Pharmaceutical composition for inhalation Sep. 23, 2014
-
Patent Title: Chlorothiophene-isoxazoles as inhibitors of coagulation factors xa and thrombin Sep. 16, 2014
-
Patent Title: Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application Sep. 16, 2014
Government Contracts
Federal grants, loans, and purchases
- $92,326,417 2026-03-27 00:00:00 Agency: Department of Health and Human Services
- $20,735 2026-03-25 00:00:00 Agency: Department of Veterans Affairs
- $31,943 2026-03-25 00:00:00 Agency: Department of Veterans Affairs
- $29,421 2026-03-25 00:00:00 Agency: Department of Veterans Affairs
- $70,050 2026-03-20 00:00:00 Agency: Department of Veterans Affairs
- $841 2026-03-19 00:00:00 Agency: Department of Justice
- $560 2026-03-19 00:00:00 Agency: Department of Justice
- $20,174 2026-03-19 00:00:00 Agency: Department of Veterans Affairs
- $12,609 2026-03-19 00:00:00 Agency: Department of Veterans Affairs
- $14,570 2026-03-19 00:00:00 Agency: Department of Justice
- $224 2026-03-19 00:00:00 Agency: Department of Justice
- $15,411 2026-03-19 00:00:00 Agency: Department of Veterans Affairs
- $2,800 2026-03-18 00:00:00 Agency: Department of Justice
- $2,542 2026-03-18 00:00:00 Agency: Department of Justice
- $6,164 2026-03-17 00:00:00 Agency: Department of Justice
- $3,643 2026-03-17 00:00:00 Agency: Department of Justice
- $1,457 2026-03-17 00:00:00 Agency: Department of Justice
- $5,044 2026-03-17 00:00:00 Agency: Department of Justice
- $5,044 2026-03-17 00:00:00 Agency: Department of Justice
- $635 2026-03-16 00:00:00 Agency: Department of Justice
- $6,445 2026-03-13 00:00:00 Agency: Department of Justice
- $1,793 2026-03-12 00:00:00 Agency: Department of Justice
- $336 2026-03-11 00:00:00 Agency: Department of Justice
- $2,522 2026-03-11 00:00:00 Agency: Department of Justice
- $1,401 2026-03-11 00:00:00 Agency: Department of Justice
- $3,026 2026-03-09 00:00:00 Agency: Department of Justice
- $1,121 2026-03-04 00:00:00 Agency: Department of Justice
- $3,811 2026-03-04 00:00:00 Agency: Department of Justice
- $560 2026-03-03 00:00:00 Agency: Department of Justice
- $1,961 2026-03-03 00:00:00 Agency: Department of Justice
- $1,513 2026-02-27 00:00:00 Agency: Department of Justice
- $2,242 2026-02-25 00:00:00 Agency: Department of Justice
- $448 2026-02-25 00:00:00 Agency: Department of Justice
- $2,802 2026-02-24 00:00:00 Agency: Department of Justice
- $2,522 2026-02-17 00:00:00 Agency: Department of Justice
- $60,000 2026-02-12 00:00:00 Agency: Department of Justice
- $25,106 2026-02-10 00:00:00 Agency: Department of Veterans Affairs
- $17,156 2026-02-10 00:00:00 Agency: Department of Justice
- $504 2026-02-10 00:00:00 Agency: Department of Justice
- $448 2026-02-09 00:00:00 Agency: Department of Justice
- $1,939 2026-01-29 00:00:00 Agency: Department of Justice
- $12,441 2025-12-29 00:00:00 Agency: Department of Health and Human Services
- $12,572 2025-12-29 00:00:00 Agency: Department of Health and Human Services
- $0 2025-12-15 00:00:00 Agency: Department of Veterans Affairs
- $40,162 2025-10-07 00:00:00 Agency: Smithsonian Institution
- $176,565 2025-09-09 00:00:00 Agency: Department of State
- $24,873,330 2025-09-08 00:00:00 Agency: Department of Health and Human Services
- $1,939 2025-09-03 00:00:00 Agency: Department of Justice
- $3,142 2025-07-11 00:00:00 Agency: Department of Justice
- $3,472 2025-07-11 00:00:00 Agency: Department of Defense
Government Contracts
Estimated quarterly amount awarded to SNY from public contracts
SNY News
Recent insights relating to SNY
CNBC Recommendations
Recent picks made for SNY stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SNY
SNY Analyst Ratings
SNY Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
SNY Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $SNY stock a Buy, Sell, or Hold?
- What is the price target for $SNY stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
SNY Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $SNY stock?
- Who owns the most shares of $SNY stock?
- What funds own $SNY stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
SNY Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SNY Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
About SNY
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Sanofi American Depositary Shares (Each representing one-half of Executive Compensation
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|